[{"address1": "South Tower", "address2": "140 E Ridgewood Avenue Suite 415", "city": "Paramus", "state": "NJ", "zip": "07652", "country": "United States", "phone": "201 940 7236", "website": "https://polaryx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Polaryx Therapeutics, Inc., clinical-stage biotechnology company, develops small molecule and gene therapy treatments for lysosomal storage disorders. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Alex  Yang J.D., L.L.M.", "title": "CEO & Chair of Board", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  John O", "age": 52, "title": "Chief Investment Officer & Director", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrijay  Vijayan M.B.A., Ph.D.", "age": 57, "title": "Chief Scientific & Business Development Officer", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wuxin  Zhu P.M.P., Ph.D.", "age": 45, "title": "Chief Chemistry, Manufacturing & Controls Officer", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lisa L. Bollinger M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 35.0, "open": 33.6, "dayLow": 16.7001, "dayHigh": 33.6, "regularMarketPreviousClose": 35.0, "regularMarketOpen": 33.6, "regularMarketDayLow": 16.7001, "regularMarketDayHigh": 33.6, "volume": 28912, "regularMarketVolume": 28912, "averageVolume": 25300, "averageVolume10days": 25300, "averageDailyVolume10Day": 25300, "fiftyTwoWeekLow": 16.7001, "fiftyTwoWeekHigh": 48.91, "allTimeHigh": 48.91, "allTimeLow": 20.0, "fiftyDayAverage": 35.0, "twoHundredDayAverage": 35.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1640298880, "profitMargins": 0.0, "bookValue": 0.113, "priceToBook": 194.69026, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8213000, "52WeekChange": 0.0, "SandP52WeekChange": 0.15544534, "quoteType": "EQUITY", "currentPrice": 22.0, "recommendationKey": "none", "totalCash": 5745000, "totalCashPerShare": 0.122, "totalDebt": 0, "quickRatio": 8.424, "currentRatio": 8.773, "operatingCashflow": -3314000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PLYX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "newListingDate": "2026-01-30", "cryptoTradeable": false, "regularMarketChangePercent": -37.142857, "regularMarketPrice": 22.0, "corporateActions": [{"header": "New Listing", "message": "PLYX is newly listed on Nasdaq effective Feb. 2, 2026", "meta": {"eventType": "NEW_LISTING", "dateEpochMs": 1770008400000, "exchange": "Nasdaq"}}], "regularMarketTime": 1770138241, "exchange": "NGM", "messageBoardId": "finmb_414729746", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Polaryx Therapeutics, Inc. Common Stock", "marketState": "REGULAR", "regularMarketDayRange": "16.7001 - 33.6", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 25300, "fiftyTwoWeekLowChange": 5.2999, "fiftyTwoWeekLowChangePercent": 0.3173574, "fiftyTwoWeekRange": "16.7001 - 48.91", "fiftyTwoWeekHighChange": -26.91, "fiftyTwoWeekHighChangePercent": -0.5501942, "fiftyTwoWeekChangePercent": 0.0, "fiftyDayAverageChange": -13.0, "fiftyDayAverageChangePercent": -0.37142858, "twoHundredDayAverageChange": -13.0, "twoHundredDayAverageChangePercent": -0.37142858, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1770042600000, "regularMarketChange": -13.0, "displayName": "Polaryx Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-03"}]